T 0709/17 of 10.12.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T070917.20191210
- Date of decision
- 10 December 2019
- Case number
- T 0709/17
- Petition for review of
- -
- Application number
- 10737869.7
- IPC class
- C07D 403/06A61K 31/506A61P 31/10
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- A 1-(1H-1,2,4-TRIAZOL-1-YL)BUTAN-2-OL DERIVATIVE FOR PHARMACEUTICAL USE, AND THE USE OF A 1-(1H-1,2,4-TRIAZOL-1-YL)BUTAN-2-OL DERIVATE WITH SUBSTANTIALLY UNDEFINED CRYSTAL SHAPE FOR PREPARING SAID 1-(1H-1,2,4-TRIAZOL-1-YL)BUTAN-2-OL DERIVATIVE
- Applicant name
- Medichem, S.A.
- Opponent name
- Gillard, Richard Edward
isarpatent - Patentanwälte Behnisch Barth Charles
Hassa Peckmann und Partner mbB
Actavis Group PTC ehf
FRKelly - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)European Patent Convention Art 54European Patent Convention Art 56
- Keywords
- Insufficiency of disclosure
Novelty
Inventive step - Catchword
- -
- Cited cases
- T 0928/06
Order
For these reasons it is decided that:
The appeal of the sole remaining appellant, appellant 1, is dismissed.